IRIS
RUSSO, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.982
AS - Asia 5.452
EU - Europa 2.890
SA - Sud America 1.231
AF - Africa 185
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 27
Totale 17.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.569
SG - Singapore 2.400
IT - Italia 1.238
CN - Cina 1.110
BR - Brasile 942
VN - Vietnam 576
IN - India 535
DE - Germania 381
GB - Regno Unito 340
CA - Canada 313
SE - Svezia 244
HK - Hong Kong 228
FI - Finlandia 182
AR - Argentina 97
NL - Olanda 83
ID - Indonesia 72
FR - Francia 67
RU - Federazione Russa 67
MX - Messico 62
BD - Bangladesh 60
AU - Australia 56
AE - Emirati Arabi Uniti 54
ZA - Sudafrica 54
TR - Turchia 51
CO - Colombia 49
EC - Ecuador 48
IQ - Iraq 46
EG - Egitto 45
JP - Giappone 44
PK - Pakistan 41
ES - Italia 39
CL - Cile 36
RO - Romania 36
PL - Polonia 32
UA - Ucraina 30
IL - Israele 24
SA - Arabia Saudita 23
UZ - Uzbekistan 23
EU - Europa 22
MY - Malesia 21
PH - Filippine 20
IR - Iran 19
EE - Estonia 18
GR - Grecia 18
VE - Venezuela 18
PY - Paraguay 17
KR - Corea 15
TW - Taiwan 15
CH - Svizzera 14
CZ - Repubblica Ceca 14
KE - Kenya 14
AT - Austria 12
DO - Repubblica Dominicana 11
PE - Perù 11
IE - Irlanda 10
MA - Marocco 10
DZ - Algeria 8
JO - Giordania 8
KZ - Kazakistan 8
NP - Nepal 8
PT - Portogallo 8
TN - Tunisia 8
BE - Belgio 7
MT - Malta 7
NG - Nigeria 7
UY - Uruguay 7
ET - Etiopia 6
HN - Honduras 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
GA - Gabon 5
HR - Croazia 5
LT - Lituania 5
MD - Moldavia 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
NO - Norvegia 4
OM - Oman 4
SC - Seychelles 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
LK - Sri Lanka 3
TH - Thailandia 3
UG - Uganda 3
BS - Bahamas 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
Totale 17.787
Salva come PNG Salva come JPEG
Città #
San Jose 1.191
Chandler 981
Singapore 937
Ashburn 611
Dallas 531
Santa Clara 370
Milan 324
Bengaluru 321
Hefei 309
Munich 277
Princeton 274
Lawrence 267
Hong Kong 217
Ho Chi Minh City 202
Ottawa 191
Chicago 188
London 187
Beijing 177
Catanzaro 159
Wilmington 154
Hanoi 115
Des Moines 99
São Paulo 98
Turku 94
Boardman 91
New York 86
Helsinki 79
Los Angeles 63
Redwood City 53
Rome 51
Catania 45
Orem 44
Amsterdam 41
Brooklyn 40
Shanghai 34
Haiphong 33
Boston 32
Council Bluffs 32
Guangzhou 32
Tokyo 32
Rio de Janeiro 31
Montreal 30
Chennai 29
Da Nang 28
The Dalles 28
Atlanta 26
Curitiba 25
Warsaw 25
Columbus 24
Naples 24
Toronto 24
Bari 23
Norwalk 23
Tashkent 22
Bogotá 21
Florence 21
Melbourne 21
Pune 21
Redmond 21
Brasília 20
Cairo 20
Johannesburg 20
Istanbul 19
Shenzhen 19
Mumbai 18
Stockholm 18
Guayaquil 17
Thái Bình 17
Jakarta 16
Mexico City 16
Padova 16
Porto Alegre 16
Hyderabad 15
San Francisco 15
Seattle 15
Sydney 15
Timisoara 15
Dhaka 14
Manchester 14
Phoenix 14
San Nicola Manfredi 14
Biên Hòa 13
Campinas 13
Falls Church 13
Messina 13
Nairobi 13
Buenos Aires 12
Hải Dương 12
Madrid 12
Santiago 12
Baghdad 11
Bologna 11
Olomouc 11
Palermo 11
West Jordan 11
Ankara 10
Belo Horizonte 10
Charlotte 10
Guarulhos 10
Jeddah 10
Totale 10.110
Salva come PNG Salva come JPEG
Nome #
Adherence to therapy and adverse drug reactions: is there a link? 287
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 247
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 230
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 165
Genetics of reflex seizures and epilepsies in humans and animals 158
Role of anatomical variations in chronic non polipoid rhinosinusitis 137
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 132
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 118
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 116
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 112
Efficacy and safety of bevacizumab in glioblastomas 110
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 109
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 107
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 101
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 101
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis An Observational Study 100
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 97
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 97
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 92
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 91
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 90
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 88
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 85
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 85
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 84
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 83
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 83
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 83
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 83
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 82
Melaena following use of the cholinesterase inhibitor rivastigmine 82
New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review 82
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 80
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 80
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 79
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 79
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 79
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 78
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 78
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 78
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 77
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 77
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 77
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 77
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 77
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 76
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 76
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 76
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 76
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 74
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 73
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 73
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 72
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 72
Adverse drug reactions related to drug administration in hospitalized patients. 72
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 71
Status epilepticus in pregnancy: a literature review and a protocol proposal 71
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 71
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome 71
Classical differentiation protocols upregulate the expression of the axon guidance genes PLXNA2 and SEMA3C in SH-SY5Y neuroblastoma cells 70
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 70
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 69
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 69
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 69
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 69
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 69
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 69
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 69
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 69
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 68
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 68
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 68
The potential role of cannabinoids in epilepsy treatment. 67
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 67
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 67
Renal denervation for resistant hypertension 66
Pharmacokinetic considerations about antiseizure medications in the elderly 66
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 66
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 66
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 66
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 65
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 65
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy 65
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 64
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 64
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy 63
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  63
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 63
Methodological issues associated with clinical trials in epilepsy 63
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 63
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System 63
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 63
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 63
Abatacept in psoriatic arthritis: Case report and short review. 62
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 62
Rare and very rare adverse effects of clozapine 62
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 61
Microbiota-gut brain axis involvement in neuropsychiatric disorders 61
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 61
A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients 61
Totale 8.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 46 43 9
2021/2022942 19 14 20 229 39 32 30 180 113 91 147 28
2022/20232.578 579 211 90 234 241 224 18 183 395 165 176 62
2023/20241.402 204 174 137 108 102 254 80 52 24 78 53 136
2024/20253.872 531 194 185 151 269 487 228 155 449 185 430 608
2025/20268.447 470 833 1.027 1.339 927 362 1.220 563 1.127 579 0 0
Totale 18.245